CD22 and autoimmune disease: ATA B cells can decrease CD5 in middle age and increase CD11b++CD22++ in ZAP70–CD5–, generating old age leukemia/lymphoma with autoimmune disease and control Thy-1, also ZAP70+CD5+ with CD11b+CD22+.